Trade Bristol Myers ^BMY

Bristol Myers Squibb Leans On AI ALS Pact As Valuation Question Persists

First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial

Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial

Procyon Advisors LLC Sells 20,349 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Colgate-Palmolive Board And Asia Leadership Shifts Spark Value Questions

What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.

E. Ohman J or Asset Management AB Buys 46,000 Shares of Bristol Myers Squibb Company $BMY

Insitro and Bristol Myers Squibb expand ALS collaboration | BioWorld

Enhanced dynamic risk stratification of smoldering multiple myeloma

Wealth Enhancement Advisory Services LLC Purchases 318,898 Shares of Bristol Myers Squibb Company $BMY

Replimune's Oncolytic Viral Therapy For Melanoma Faces Second Shot At FDA Approval

Opdivo's New cHL Approvals Reframe Bristol-Myers Squibb Growth Story

NorthCrest Asset Manangement LLC Has $24.56 Million Stock Position in Bristol Myers Squibb Company $BMY - Daily Political

A Look At Bristol Myers Squibb (BMY) Valuation As Recent Results Shape Growth And Cost Outlook

20,156 Shares in Bristol Myers Squibb Company $BMY Purchased by MFG Wealth Management Inc. - Stock Observer

Bristol Myers Squibb Company $BMY Shares Acquired by TruWealth Advisors LLC - Daily Political

Bristol Myers Squibb Gets Expanded Opdivo Approval in U.S., Europe | Morningstar

In the U.S., FDA approval establishes Opdivo in combination

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab) | Morningstar

Union Bancaire Privee UBP SA Boosts Stake in Bristol Myers Squibb Company $BMY

Miller Global Investments LLC Invests $1.11 Million in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Purchased by Mirabella Financial Services LLP

Union Bancaire Privee UBP SA Boosts Position in Bristol Myers Squibb Company $BMY - Daily Political

20,650 Shares in Bristol Myers Squibb Company $BMY Bought by Miller Global Investments LLC - Daily Political

Bristol Myers Squibb Kidney Cancer Trial Tests Valuation And Pipeline Depth

Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium

International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data

These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity

Bristol Myers Squibb Tests New Protein Degradation Cancer Drug In Humans

12,955 Shares in Bristol Myers Squibb Company $BMY Purchased by Investment Research Partners LLC - Daily Political

How Mezigdomide Trial Progress And Sotyktu Expansion At Bristol Myers Squibb (BMY) Has Changed Its Investment Story

WBI Investments LLC Has $2.70 Million Stock Holdings in Bristol Myers Squibb Company $BMY

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

Danske Bank A S Makes New $71.59 Million Investment in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Stake Boosted by Achmea Investment Management B.V.

Thymic health and immunotherapy outcomes in patients with cancer

The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study

Thymic health consequences in adults

Bristol Myers Squibb (NYSE:BMY) Price Target Raised to $60.00

How New Oral Immunology Wins At Bristol Myers Squibb (BMY) Have Changed Its Investment Story

HSBC Issues Positive Forecast for Bristol Myers Squibb (NYSE:BMY) Stock Price - Daily Political

Bank of Nova Scotia Raises Stock Position in Bristol Myers Squibb Company $BMY

Chevy Chase Trust Holdings LLC Cuts Stock Position in Bristol Myers Squibb Company $BMY - Markets Daily

BNP Paribas Decreases Stake in Bristol Myers Squibb Company $BMY

Chevy Chase Trust Holdings LLC Sells 35,963 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial

Banco Bilbao Vizcaya Argentaria S.A. Has $29.60 Million Stock Holdings in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Aquatic Capital Management LLC

Does Colgate-Palmolive's (CL) New Board Voice and Dividend Bump Hint at a Shifting Capital Play? - Simply Wall St News

Contineum Therapeutics Highlights PIPE-791 IPF Trial, J&J-Backed PIPE-307 Catalysts at Leerink Conference

Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer

M&T Bank Corp Has $34.43 Million Position in Bristol Myers Squibb Company $BMY

Patrick Mauro Investment Advisor INC. Purchases Shares of 56,125 Bristol Myers Squibb Company $BMY - Markets Daily

Prudential PLC Acquires 36,159 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY is Independent Franchise Partners LLP's 2nd Largest Position

Bristol Myers Squibb Company $BMY Shares Sold by Dodge & Cox

iSAM Funds UK Ltd Makes New $2.36 Million Investment in Bristol Myers Squibb Company $BMY - Stock Observer

Cadence Bank Increases Stock Holdings in Bristol Myers Squibb Company $BMY

Patrick Mauro Investment Advisor INC. Makes New Investment in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company (NYSE:BMY) Given Average Rating of "Hold" by Brokerages - Stock Observer

Eliquis Outperforms Xarelto in Safety for Treating Deep Blood Clots, ETPharma

Bristol Myers Squibb Company $BMY Shares Purchased by Te Ahumairangi Investment Management Ltd - Stock Observer

Opdualag (Bristol-Myers Squibb) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Bristol Myers Squibb Company $BMY Shares Sold by Martingale Asset Management L P

143,691 Shares in Bristol Myers Squibb Company $BMY Acquired by Entropy Technologies LP

Martingale Asset Management L P Has $21.75 Million Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Bokf Na Boosts Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Employees Retirement System of Texas - Stock Observer

Quadrature Capital Ltd Purchases Shares of 532,436 Bristol Myers Squibb Company $BMY - Daily Political

Mackenzie Financial Corp Acquires 149,701 Shares of Bristol Myers Squibb Company $BMY - Daily Political

A Look At Bristol Myers Squibb (BMY) Valuation After Recent Share Price Volatility

Merck's WELIREG Kidney Cancer Trials Deepen Oncology Growth Story

Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight

Bristol Myers Squibb Company $BMY Shares Purchased by Franklin Resources Inc. - Stock Observer

Piper Sandler Sees Path to Growth for Bristol-Myers Squibb Company (BMY) After Eliquis Patent Expiry

How Investors May Respond To Bristol Myers (BMY) Mezigdomide Successor-2 Data And New Sotyktu Approval

Richard Bernstein Advisors LLC Lowers Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Capital Group Private Client Services Inc.

How big business is rewriting the U.S. sustainability story

BioNTech Founders to Leave Company by 2026 for New mRNA Venture, ETPharma

UBS Boosts Bristol-Myers Squibb (BMY) Price Target as Milvexian Data Looms

LGT Fund Management Co Ltd. Has $372,000 Stock Position in Bristol Myers Squibb Company $BMY

Abecma (Bristol-Myers Squibb) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Bristol Myers Squibb Pipeline Update With New TYK2 And CELMoD Milestones

Bristol-Myers Squibb Readies New Growth Drivers In Immunology And Cancer

Banque Cantonale Vaudoise Acquires 26,347 Shares of Bristol Myers Squibb Company $BMY

Van ECK Associates Corp Acquires 3,982,439 Shares of Bristol Myers Squibb Company $BMY - Daily Political

LGT Fund Management Co Ltd. Has $372,000 Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics

B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

Fed Independence on the Line? Political Influence in 2026

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

US Economic Outlook 2026: A Roubini Analysis

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Trading wisdom: how can I improve myself as a trader?

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

EQV stock price today: Is EQV Ventures a good investment?

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Russia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict

US Economic Signals: Inflation Concerns and Growth Challenges

Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions

Apple Slashes App Store Commissions in China for Developers

Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis

Aussie Dollar Sees Surge in Bullish Bets Ahead of Reserve Bank of Australia Rate Decision

India's Silver Demand Surge: New Loan Framework Boosts Market

ADP Employment Data and the Fed's Policy Path: A Closer Look